eli lilly ceo on who advising against using remdesivir to treat covid-19
Published 3 years ago • 15K plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
2:38
eli lilly ceo on drug that could aid covid-19 recovery when paired with remdesivir
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
1:41
eli lilly ceo explains supply chain of covid-19 antibody drug
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
4:37
eli lilly ceo: covid-19 antibody treatment will help reduce hospitalizations
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
4:03
eli lilly ceo: alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
-
9:11
eli lilly ceo: competition in pharma | mad money | cnbc
-
23:50
eli lilly ceo says virus will be 'endemic'
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
0:46
remdesivir has little effect on covid-19 mortality: who study
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
8:21
eli lilly ceo talks partnering with abcellera biologics to co-develop a coronavirus cure
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
3:54
gilead ceo on treating covid-19: 'we're not finished with remdesivir'
-
4:21
eli lilly cfo on q2 earnings and coronavirus treatment
-
3:32
eli lilly ceo david ricks on the end of antibody study in hospitalized patients
-
1:05
eli lilly files for emergency use authorization of its covid-19 antibody drug
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
5:19
watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results